Jupiter Asset Management LTD Atea Pharmaceuticals, Inc. Transaction History

Jupiter Asset Management LTD

  • $11 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022
SELL
$5.33 - $8.18 $39,889 - $61,219
-7,484 Reduced 2.77%
263,056 $1.86 Million
Q1 2022

May 11, 2022
BUY
$5.5 - $9.19 $676,186 - $1.13 Million
122,943 Added 83.3%
270,540 $1.95 Million
Q4 2021

Feb 11, 2022
BUY
$7.67 - $44.59 $956,855 - $5.56 Million
124,753 Added 546.11%
147,597 $1.33 Million
Q3 2021

Nov 10, 2021
BUY
$21.33 - $35.06 $487,262 - $800,910
22,844 New
22,844 $801,000

Others Institutions Holding AVIR

# of Institutions
112
Shares Held
52.4M
Call Options Held
900
Put Options Held
126K
View Full List

About Atea Pharmaceuticals, Inc.

AVIR Quotes by TradingView
  • Ticker AVIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,258,600
  • Market Cap $271M
  • Description
  • Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...
More about AVIR
Track This Portfolio

Track Jupiter Asset Management LTD Portfolio

Follow Jupiter Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jupiter Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Jupiter Asset Management LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email